Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Net Income ContractionContracting
Percentile Rank86
3Y CAGR+16.2%
5Y CAGR+19.7%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+16.2%/yr
Annual compound
5Y CAGR
+19.7%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $316.89M | -28.6% |
| 2024 | $444.09M | +57.7% |
| 2023 | $281.59M | +39.3% |
| 2022 | $202.13M | -49.8% |
| 2021 | $402.71M | +212.0% |
| 2020 | $129.09M | +278.7% |
| 2019 | $-72.24M | +10.1% |
| 2018 | $-80.33M | -227.6% |
| 2017 | $62.97M | +161.1% |
| 2016 | $-103.02M | - |